![Ryan Arnold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ryan Arnold
Corporate Officer/Principal at
STOKE THERAPEUTICS, INC.
Profile
Ryan Arnold is currently Senior VP & Head-Global Medical Affairs at Stoke Therapeutics, Inc. Former positions include Chief Medical Officer at BioCryst Pharmaceuticals, Inc. from 2022 to 2024, Vice President-Medical Affairs at SAGE Therapeutics, Inc., and Principal at Biogen, Inc. Education includes a doctorate from Michigan State University and an undergraduate degree from Oakland University (Michigan).
Ryan Arnold active positions
| Companies | Position | Start |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Former positions of Ryan Arnold
| Companies | Position | End |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 05/09/2024 |
| BIOGEN INC. | Corporate Officer/Principal | - |
| SAGE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Ryan Arnold
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
27
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oakland University (Michigan)
 Oakland University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
- Stock Market
- Insiders
- Ryan Arnold
